Statistics
Publications
13
Citations
794
H-Index
12
Active since
1997
Mark Ozeck is an author at Pfizer (United States) specializing in medicine, molecular oncology, and oncology.
Publications per year
1997–2021
13
13
HIP1–ALK, A Novel ALK Fusion Variant that Responds to Crizotinib
Douglas D. Fang, Bin Zhang, Qingyang Gu et al. · Journal of Thoracic Oncology · 2014 · 95 citations · Full text
1–5 of 13